SCHEMBL4926772

SCHEMBL4926772

Cc1cccc(Cl)c1N(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.44
DOT1L Q8TEK3 2/20 0.41
MCOLN3 Q8TDD5 1/20 0.40
POLB P06746 1/20 0.40
S1PR4 O95977 1/20 0.38
ESR1 P03372 2/20 0.35
PTPN1 P18031 1/20 0.35
CES1 P23141 1/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
OPRM1 P35372 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15362296 0.86 TSHR (0.41) PTPN1CES1MEN1KMT2ATSHR
SCHEMBL7917024 0.79 ESR1 (0.38) MCOLN3POLBS1PR4ESR1GAA
SCHEMBL21395985 0.77 ESR1 (0.40) HDAC6DOT1LS1PR4ESR1GAA
SCHEMBL13569448 0.74 ALDH1A1 (0.42) ESR1PTPN1CES1MAPTMEN1
SCHEMBL28597260 0.74 POLB (0.43) MCOLN3POLBMEN1KMT2ALMNA
SCHEMBL30962463 0.73 CES1 (0.33) HDAC6PTPN1CES1MEN1KMT2A
SCHEMBL6120419 0.73 ALDH1A1 (0.50) POLBMEN1KMT2ALMNA
SCHEMBL5798012 0.72 S1PR4 (0.40) HDAC6POLBS1PR4ESR1GAA
SCHEMBL11742715 0.72 MYC (0.45) POLBMAPTMEN1KMT2ALMNA
SCHEMBL22336611 0.71 ALDH1A1 (0.48) HDAC6MCOLN3CES1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249318-A1 Process for phenylacetic acid derivatives ACEMOGLU MURAT 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249318-A1 Process for phenylacetic acid derivatives ALDH7A1, CYP4F11, CYP2A6 HDAC6 1103/4885DOT1L 2265/4885MCOLN3 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.